ATG4B and chronic myelogenous leukemia, BCR-ABL1 positive: Previous studies have demonstrated that ATG4B expression is increased and associated with poor prognosis in Chronic Myeloid Leukemia (CML), breast cancer, and oral cancer [22–24].